Viewing Study NCT01453920


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2025-12-26 @ 3:11 AM
Study NCT ID: NCT01453920
Status: COMPLETED
Last Update Posted: 2012-08-28
First Post: 2011-10-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing
Sponsor: University Health Network, Toronto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module